Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice

Aim: Although metformin treatment has been reported to reduce the risk of cardiovascular events in patients with type 2 diabetes, the underlying mechanisms have not been elucidated fully. Here we assessed atherosclerotic lesion formation in newly established 2 mouse lines with different blood glucos...

Descripción completa

Detalles Bibliográficos
Autores principales: Asai, Akira, Shuto, Yuki, Nagao, Mototsugu, Kawahara, Momoyo, Miyazawa, Teruo, Sugihara, Hitoshi, Oikawa, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927811/
https://www.ncbi.nlm.nih.gov/pubmed/30971640
http://dx.doi.org/10.5551/jat.48223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927811/
https://www.ncbi.nlm.nih.gov/pubmed/30971640
http://dx.doi.org/10.5551/jat.48223

Ejemplares similares